| Ident. | Authors (with country if any) | Title |
|---|
| 000002 (2011) |
Wassilios G. Meissner ; Mark Frasier ; Thomas Gasser ; Christopher G. Goetz ; Andres Lozano ; Paola Piccini ; José A. Obeso ; Olivier Rascol ; Anthony Schapira ; Valerie Voon ; David M. Weiner ; François Tison ; Erwan Bezard | Priorities in Parkinson's disease research |
| 000100 (2010) |
Anthony H. V. Schapira ; Stefan Albrecht ; Paolo Barone ; Cynthia L. Comella ; Michael P. Mcdermott ; Yoshikuni Mizuno ; Werner Poewe ; Olivier Rascol ; Kenneth Marek | Rationale for delayed‐start study of pramipexole in Parkinson's disease: The PROUD study |
| 000102 (2010) |
Patrice Pran ; Andrea Cherubini ; Francesca Assogna ; Fabrizio Piras ; Carlo Quattrocchi ; Antonella Peppe ; Pierre Celsis ; Olivier Rascol ; Jean-Franois Dmonet ; Alessandro Stefani ; Mariangela Pierantozzi ; Francesco Ernesto Pontieri ; Carlo Caltagirone ; Gianfranco Spalletta ; Umberto Sabatini | Magnetic resonance imaging markers of Parkinsons disease nigrostriatal signature |
| 000106 (2011) |
Olivier Rascol ; Andres Lozano ; Matthew Stern ; Werner Poewe | Milestones in Parkinson's disease therapeutics |
| 000217 (2008) |
C. Warren Olanow ; Robert A. Hauser ; Joseph Jankovic ; William Langston ; Anthony Lang ; Werner Poewe ; Eduardo Tolosa ; Fabrizio Stocchi ; Eldad Melamed ; Eli Eyal ; Olivier Rascol | A randomized, double‐blind, placebo‐controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics |
| 000324 (2010) |
Fabrizio Stocchi ; Olivier Rascol ; Karl Kieburtz ; Werner Poewe ; Joseph Jankovic ; Eduardo Tolosa ; Paulo Barone ; Anthony E. Lang ; C. Warren Olanow | Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE‐PD study |
| 000362 (2008) |
Hubert H. Fernandez ; Dag Aarsland ; Gilles Fénelon ; Joseph H. Friedman ; Laura Marsh ; Alexander I. Tröster ; Werner Poewe ; Olivier Rascol ; Cristina Sampaio ; Glenn T. Stebbins ; Christopher G. Goetz | Scales to assess psychosis in Parkinson's disease: Critique and recommendations |
| 000478 (2010) |
Juliana Bronzova ; Cristina Sampaio ; Robert A. Hauser ; Anthony E. Lang ; Olivier Rascol ; Ad Theeuwes ; Serge V. Van De Witte ; Guus Van Scharrenburg | Double‐blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease |
| 000547 (2011) |
Susan H. Fox ; Regina Katzenschlager ; Shen-Yang Lim ; Bernard Ravina ; Klaus Seppi ; Miguel Coelho ; Werner Poewe ; Olivier Rascol ; Christopher G. Goetz ; Cristina Sampaio | The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease |
| 000669 (2006) |
Olivier Rascol ; Bruno Dubois ; Alexandre Castro Caldas ; Stephen Senn ; Susanna Del Signore ; Andrew Lees | Early piribedil monotherapy of Parkinson's disease: A planned seven‐month report of the REGAIN study |
| 000688 (2010) |
Joaquim J. Ferreira ; Dulce Neutel ; Tiago Mestre ; Miguel Coelho ; Mário M. Rosa ; Olivier Rascol ; Cristina Sampaio | Skin cancer and Parkinson's disease |
| 000691 (2010) |
Birgit Högl ; Isabelle Arnulf ; Cynthia Comella ; Joaquim Ferreira ; Alex Iranzo ; Barbara Tilley ; Claudia Trenkwalder ; Werner Poewe ; Olivier Rascol ; Cristina Sampaio ; Glenn T. Stebbins ; Anette Schrag ; Christopher G. Goetz | Scales to assess sleep impairment in Parkinson's disease: Critique and recommendations |
| 000737 (2010) |
Olivier Rascol ; Jean-Philippe Azulay ; Olivier Blin ; Anne-Marie Bonnet ; Christine Brefel-Courbon ; Pierre Césaro ; Philippe Damier ; Bérengère Debilly ; Frank Durif ; Monique Galitzky ; Jean-Marie Grouin ; Sylvie Pennaforte ; Gabriel Villafane ; Sadek Yaici ; Yves Agid | Orodispersible sublingual piribedil to abort OFF episodes: A single dose placebo‐controlled, randomized, double‐blind, cross‐over study |
| 000744 (2007) |
Robert A. Hauser ; Olivier Rascol ; Amos D. Korczyn ; A. Jon Stoessl ; Ray L. Watts ; Werner Poewe ; Peter P. De Deyn ; Anthony E. Lang | Ten‐year follow‐up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa |
| 000775 (2010) |
Carlo Colosimo ; Pablo Martínez-Martín ; Giovanni Fabbrini ; Robert A. Hauser ; Marcelo Merello ; Janis Miyasaki ; Werner Poewe ; Cristina Sampaio ; Olivier Rascol ; Glenn T. Stebbins ; Anette Schrag ; Christopher G. Goetz | Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations |
| 000866 (2010) |
Robert A. Hauser ; Anthony H. V. Schapira ; Olivier Rascol ; Paolo Barone ; Yoshikuni Mizuno ; Laurence Salin ; Monika Haaksma ; Nolwenn Juhel ; Werner Poewe | Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease |
| 000930 (2009) |
Olivier Rascol ; Ludwig Schelosky | 123I‐metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders |
| 000A76 (2003) |
Olivier Rascol ; Pierre Payoux ; Fabienne Ory ; Joaquim J. Ferreira ; Christine Brefel-Courbon ; Jean-Louis Montastruc | Limitations of current Parkinson's disease therapy |
| 000A96 (2009) |
Donald Grosset ; Angelo Antonini ; Margherita Canesi ; Gianni Pezzoli ; Andrew Lees ; Karen Shaw ; Esther Cubo ; Pablo Martinez-Martin ; Olivier Rascol ; Laurence Negre-Pages ; Ana Senard ; Johannes Schwarz ; Karl Strecker ; Heinz Reichmann ; Alexander Storch ; Matthias Löhle ; Fabrizio Stocchi ; Katherine Grosset | Adherence to antiparkinson medication in a multicenter European study |
| 000D94 (2005) |
Christopher G. Goetz ; Werner Poewe ; Olivier Rascol ; Cristina Sampaio | Evidence‐based medical review update: Pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004 |
| 000E78 (2003) |
Ebba Lohmann ; Magali Periquet ; Vincenzo Bonifati ; Nick W. Wood ; Giuseppe De Michele ; Anne-Marie Bonnet ; Valérie Fraix ; Emmanuel Broussolle ; Martin W. I. M. Horstink ; Marie Vidailhet ; Patrice Verpillat ; Thomas Gasser ; David Nicholl ; Hélio Teive ; Salmo Raskin ; Olivier Rascol ; Alain Destée ; Merle Ruberg ; Francesca Gasparini ; Giuseppe Meco ; Yves Agid ; Alexandra Durr ; Alexis Brice | How much phenotypic variation can be attributed to parkin genotype? |
